EPO and obesity due to melanocortin 4 receptor deficiency: In mouse models of diabetes and obesity, EPO treatment in male mice with protein Tyr phosphatase knock out (PTP1B−/−) and in ob/ob mice decreased blood glucose and body weight gain (Teng et al., 2011; Katz et al., 2010).